AD/PDTM 2023 International Congress of Alzheimer’s and Parkinson’s Disease | March 28 – April 1, 2023
March 28, 2023 — Church et al.
Fosgonimeton Promotes Survival and Reduces Protein Pathology in Primary Neuron Models of Alzheimer’s and Parkinson’s Disease
March 28, 2023 — Johnston et al.
Fosgonimeton Is Neuroprotective and Rescues Cognitive Performance in Models of Neuroinflammation
March 28, 2023 — Reda et al.
Neuroprotective Effects of Fosgonimeton on Dopaminergic Neurons Are Mediated by Signaling Effectors Downstream of HGF/MET